Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

Published:2023-09 Issue: Volume:63 Page:102172
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Wang Jie,Chen Hongyu,Tang Zihuan,Zhang Jinquan,Xu Yuanwei,Wan Ke,Hussain Kifah,Gkoutos Georgios V.^ORCID,Han Yuchi,Chen Yucheng

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis;Lane;Circulation,2019

2. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement;Castaño;Eur Heart J,2017

3. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction;González-López;Eur Heart J,2015

4. Specific therapy for transthyretin cardiac amyloidosis: a systematic literature review and evidence-based recommendations;Marques;J Am Heart Assoc,2020

5. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade;Bulawa;Proc Natl Acad Sci U S A,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-Analysis;Tomography;2024-08-16

2. Transthyretin Stabilizer Therapy in Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis;American Journal of Therapeutics;2024-08-07

3. Prevalence of cardiac amyloidosis in atrial fibrillation: a CMR study prior to catheter ablation;Heart and Vessels;2024-07-29

4. Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data;Journal of the American Heart Association;2024-07-16

5. Interdisciplinary Multidimensional Assessment of Transthyretin Amyloidosis before and after Tafamidis;Life;2023-12-07